source
- World's first personalized gene-editing therapy costs $1.65 million per patient, project director saysAt a rare disease conference in Oxford, Fyodor Urnov disclosed that the world's first therapy designed to correct an individual’s unique genetic mutation cost $1.65 million to produce. The treatme…
- AI-driven biotech Enveda secures $311 million Series E to advance plant-derived drug candidatesEnveda Biosciences, a Colorado AI drug discovery company, announced a $311 million Series E financing round, one of the larger biotech raises this year. The firm uses artificial intelligence to sc…